Johnson & Johnson's Vision Segment Targets Up to High-Single Digit Long-Term Growth, RBC Says

MT Newswires Live03-30

Johnson & Johnson's (JNJ) Vision segment targets to deliver mid-to-high single digit growth in the long term, with catalysts like upcoming product launches, contact lens market recovery, and planned increase in capital allocation, RBC Capital Markets said in a Monday note.

Vision is one of the three strategic growth priorities of Johnson & Johnson's MedTech division and is "uniquely positioned" to benefit from the company's digital/AI, manufacturing and regulatory capabilities, RBC said, as it noted the segment's greenfield opportunity in a 2-billion addressable market.

Management expects daily disposable contact lenses and presbyopia-correcting intraocular lenses to continue driving growth, according to the note. Vision generated 2025 sales of $5.5 billion, a 5.3% increase led by the surgical vision and contact lens products, RBC said.

RBC maintained an outperform rating on Johnson & Johnson, with a $255 price target.

Price: 242.20, Change: +1.75, Percent Change: +0.73

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment